CAPE TOWN – A new antiretroviral drug was supposed to be a game-changer for South Africa, which has one of the largest HIV-positive populations in the world. The drug, dolutegravir, was cheap, had few side effects, and – most importantly – it suppressed the virus quickly. But after a few months on the treatment, many … Continue reading This Research Centre Wants Your Liver – If You’re From Africa